Saturday, October 24, 2009

Google Alert - thyroid

Google News Alert for: thyroid

Exelixis and Bristol-Myers Squibb Report New Phase 2 Data for XL184 in ...
Reuters
RET is mutationally activated in papillary thyroid cancer (PTC) and in both familial and sporadic forms of medullary thyroid cancer (MTC). ...
See all stories on this topic
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Patients With Non ...
Reuters
This Phase 3 trial was started based on the results from Phase 2 clinical trials evaluating Nexavar in patients with advanced thyroid cancer. ...
See all stories on this topic
Diabetes drug may also help in weight loss
Los Angeles Times
The FDA has also raised questions about whether the medication can cause thyroid tumors, said Dr. Mitchell S. Roslin, chief of obesity surgery at Lenox Hill ...
See all stories on this topic
Monthly Prescribing Reference
Phase 3 study of Nexavar for the treatment of non-responsive thyroid cancer
Monthly Prescribing Reference
... evaluate Nexavar (sorafenib tablets) for the treatment of patients with iodine-refractory, locally advanced or metastatic differentiated thyroid cancer. ...
See all stories on this topic
ModernMedicine
Risks Associated With Thyroid Surgery in the Elderly Explored Study finds ...
ModernMedicine
FRIDAY, Oct. 23 (HealthDay News) -- Compared with more youthful patients, thyroid surgery presents few additional risks when performed in elderly patients, ...
See all stories on this topic
Thyroid Medications: What's the Difference?
EmpowHer (blog)
Prescription thyroid medications for hormone supplementation may be synthetic, natural (tablets made from pig thyroid gland) or bioidentical (made at a ...
See all stories on this topic
UK health care worth emulating
Albany Times Union
We take the same thyroid medication, but she did not have to undergo unnecessary expensive tests and her treatment is free. I have seen my family members in ...
See all stories on this topic


 This once a day Google Alert is brought to you by Google.

Remove this alert.
Create another alert.
Manage your alerts.

No comments:

Followers